Effects of Bedside Compared to Outside the Room Case Presentation

January 22, 2020 updated by: University Hospital, Basel, Switzerland

Effect of Bedside Patient Case Presentation Compared to Outside the Room Case Presentation on Patient Perception of Quality of Care and Patient Outcomes: a Randomized-controlled, Multicenter Trial

Patient case presentations during ward rounds can take place at the bedside or outside the room. The best approach to patient case presentation is yet unclear. Thus, the overall aim of this multicenter, randomized-controlled study is to test the hypothesis that outside the room patient case presentation compared to bedside patient case presentation results in better outcomes across different dimensions including patient understanding and perception of quality of care as well as patient outcomes, physicians' preferences, perception of quality and effectiveness, and timing of the ward rounds, respectively.

Study Overview

Detailed Description

Patient-centered care may be defined as "providing care that is respectful of and responsive to individual patient preferences, needs, and values and ensuring that patient values guide all clinical decisions". Involving patients in all steps of the healthcare process is thus important. Yet, best presentation of patients' cases during ward rounds remains unknown. During outside the room patient case presentation, the medical team discusses difficult patient or medical issues in the team, and later presents a "patient-friendly" synthesis to the patient. Bedside patient case presentation, on the other hand, allows a patient to be part of the whole team discussion. Yet, there is concern that patients may be unable to cope with the magnitude of medical information and misunderstandings may occur. Currently, there is equipoise regarding both possibilities of patient case presentation with an important lack of trial data. We thus aim to compare the effect of bedside patient case presentation with outside the room patient case presentation during ward rounds ("Chefarztvisite") on different patient- and physician-related endpoints.

Therefore, this randomized controlled trial aims to test the hypothesis that outside the room patient case presentation compared to bedside patient case presentation results in better outcomes across different dimensions including patient understanding and perception of quality of care as well as patient outcomes, physicians' preferences, perception of quality and effectiveness, and timing of the ward rounds, respectively.

Study Type

Interventional

Enrollment (Actual)

1092

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4056
        • University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consecutive adult (>18 years) medical inpatients during their first ward round independently of their underlying disease and reason for hospital stay.

Exclusion Criteria:

  1. Patients with cognitive impairment, such as dementia/delirium
  2. Patients with paracusia.
  3. Patients who do not understand local language(s).
  4. Patients already included in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: patient case presentation Bedside
In the bedside presentation group, patient case presentation and discussions will be at bedside with direct involvement of the patient as needed.
Patient case presentation in absence or presence of Patient at bedside.
Other Names:
  • teaching round
  • bedside round
  • ward round
Active Comparator: patient case presentation Outside-the-room
In the outside the room condition, case presentation and discussions will take place outside without the patient being present. After the case presentation and discussions the team will enter the room and give the patient a short summary of the medical situation, complete the medical information and examine the patient, as needed, and discuss the next steps.
Patient case presentation Outside-the-room.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective understanding of disease and management
Time Frame: post ward round up to 36 h
average of the visual analog scale (VAS) score across the following three dimensions rated by the patient (0 "I have no knowledge at all about the situation" to 100 "I have best possible knowledge about the situation": I. Patients' subjective understanding of the disease II. Patients' subjective understanding of the therapeutic concept III. Patients' subjective understanding of the next steps
post ward round up to 36 h

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement understanding
Time Frame: post ward round up to 36 h
Patients' perception about how well the current ward round improved the understanding of each of these three components, i.e., current disease, therapeutic concept, and next steps (VAS, 0-100)
post ward round up to 36 h
Objective understanding of disease and management
Time Frame: post ward round up to 36 h

Comparison of patients' recall information regarding current main diagnosis, main therapeutic measures and next steps (qualitative information) with medical chart information.

Answers regarding current main diagnosis will be categorized as: (1) patient correctly states both pathophysiology and localization, (2) patient correctly states either pathophysiology or localization, (3) patient states neither pathophysiology nor localization (correctly) but correctly states symptoms, (4) patient correctly states that the current diagnosis is still unclear, (5) patient states incorrect information, (6) patient correctly states a secondary diagnosis relevant for the current hospitalization Answers regarding main therapeutic measures and next steps will be categorized as: (1) correct (regarding main diagnosis), (2) incorrect (regarding main diagnosis), (3) correct (regarding secondary diagnosis), (4) incorrect (regarding secondary diagnosis)

post ward round up to 36 h
Overall quality of care
Time Frame: post ward round up to 36 h
Patients' perception (each rated on a VAS 0-100) regarding: comprehensibility of information during ward round, satisfaction with care, confidence in the medical team, perceived competence of the medical team, perceived interpersonal behavior during ward round, affective response of the patients, adequacy of ward round duration (includes two additional questions asking for patients' estimations on how much time the medical team spent on their case within the ward round as well as on average per day (estimates in minutes))
post ward round up to 36 h
Follow up health status
Time Frame: 30 days follow up after study inclusion
Patients' perceived health status (EuroQol five dimensions questionnaire)
30 days follow up after study inclusion
Follow up understanding
Time Frame: 30 days follow up after study inclusion
Patients' subjective (VAS 0-100) and objective (recall as compared to objective medical chart information) understanding
30 days follow up after study inclusion
Follow up quality of hospital care
Time Frame: 30 days follow up after study inclusion
Patients' overall perspective of hospital care (Hospital Consumer Assessment of Healthcare Providers and Systems, HCAHPS)
30 days follow up after study inclusion
Follow up readmission
Time Frame: 30 days follow up after study inclusion
Patients' readmission rate since study inclusion
30 days follow up after study inclusion
Follow up duration of hospitalization
Time Frame: 30 days follow up after study inclusion
total duration of hospitalization
30 days follow up after study inclusion
Treating team satisfaction
Time Frame: post ward round up to 96 h
The treating team's satisfaction with ward round (rated on a VAS 0-100)
post ward round up to 96 h
Treating team performance
Time Frame: post ward round up to 96 h
The treating team's perceived performance in the ward round (each rated on a VAS 0-100): time management of the ward round, interaction within the medical team and with the patient during ward round, perceived time management and feasibility
post ward round up to 96 h
Treating team affect
Time Frame: post ward round up to 96 h
The treating team's affective response (rated on a VAS 0-100)
post ward round up to 96 h
Treating team preference
Time Frame: post ward round up to 96 h
The treating team's preference of bedside compared to outside the room patient case presentation (rated on a semantic differential ranging from 1 "I prefer bedside ward rounds" to 6 "I prefer ward rounds outside the room")
post ward round up to 96 h
Timeliness
Time Frame: during ward round which may last from 5 up to 30 minutes
duration of the ward round (minutes)
during ward round which may last from 5 up to 30 minutes
Communication-specific items during ward rounds
Time Frame: during ward round which may last from 5 up to 30 minutes
Rated by investigator (nominal 3-point scale (1 = yes; 2 = no; 3 = not applicable): structuring of conversation, use of patient-centered techniques, use of physician-centered techniques, dealing with emotions, conveying of complex information, negotiation of shared concepts of disease and treatment, realization of shared decision making, breaking bad news
during ward round which may last from 5 up to 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sabina Hunziker, Prof., Medical Communication, Department of Psychosomatic Medicine, University Hospital Basel, and University of Basel, Switzerland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 11, 2017

Primary Completion (Actual)

September 21, 2019

Study Completion (Actual)

October 20, 2019

Study Registration Dates

First Submitted

June 27, 2017

First Submitted That Met QC Criteria

July 4, 2017

First Posted (Actual)

July 7, 2017

Study Record Updates

Last Update Posted (Actual)

January 23, 2020

Last Update Submitted That Met QC Criteria

January 22, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Visitenstudie (2017-00991)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bedside Patient Case Presentation

Clinical Trials on patient case presentation bedside

Subscribe